The Ganzflicker experience: High probability of seeing vivid and complex pseudo-hallucinations with imagery but not aphantasia
Sign Up to like & getrecommendations! Published in 2021 at "Cortex"
DOI: 10.1016/j.cortex.2021.05.007
Abstract: There are considerable individual differences in visual mental imagery ability across the general population, including a "blind mind's eye", or aphantasia. Recent studies have shown that imagery is linked to differences in perception in the… read more here.
Keywords: imagery; ganzflicker; pseudo hallucinations; vivid ... See more keywords
DOP005 Long-term efficacy and safety of mirikizumab treatment for Crohn’s Disease: Results from the VIVID-2 open-label extension study
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Crohn's and Colitis"
DOI: 10.1093/ecco-jcc/jjae190.0044
Abstract: VIVID-2 (NCT04232553) is an ongoing open-label long-term extension study of efficacy and safety of mirikizumab (MIRI), a selective interleukin-23p19 inhibitor, in patients with moderately to severely active Crohn’s disease (CD). We present efficacy and safety… read more here.
Keywords: safety; endoscopic remission; miri; vivid ... See more keywords